Associations
newsletter
subscribe
advertise
contact
Technology
pulseTV
Buyer's Guide
Comparison Charts
Blogs
Events
Webinars
Magazine
Cardiac Diagnostics
ECG
ECG Management Systems
Holter Monitoring Systems
Stress Test Systems
Cardiac Imaging
Advanced Visualization
Angiography Systems
Cardiovascular Ultrasound
Contrast Media
CT Systems
Hybrid OR
MRI Systems
Nuclear Imaging
Cath Lab
Angiography Systems
Balloon Catheters
Hemostasis Management
Intravascular Imaging Systems
Interventional Radiology
Hybrid OR
Radial Access
Stents
Ventricular Assist Devices (VAD)
EP Lab
Ablation Systems
Cardiac Resynchronization Therapy Devices (CRT)
Implantable Cardioverter Defibrillators (ICD)
Leads, implantable devices
Pacemakers
Information Technology
Advanced Visualization
Cardiac PACS
Telecardiology
Structural Heart
Heart Valve Repair
Hybrid OR
Left Atrial Appendage (LAA) Occluders
Structural Heart Occluders/Closure Devices
NeuroVive Pharmaceutical
Sölvegatan 19
221 84 Lund
Sweden
Phone:
+ 46 (0)46 288 01 10
http://www.neurovive.com
info@neurovive.com
Product Categories: Cardiac Stem Cell/Regeneration therapy Pharmaceuticals
Related Articles
Cath Lab
600th Heart Attack Patient Recruited Into Phase III CicloMulsion CIRCUS Trial
Clinical Trial/Study
600th Heart Attack Patient Recruited Into Phase III CicloMulsion CIRCUS Trial
First Heart Attack Patient Treated in European Cardioprotection Phase III Trial
Stents
600th Heart Attack Patient Recruited Into Phase III CicloMulsion CIRCUS Trial
NeuroSigma Licenses UCLA's Thin-Film Nitinol Stent Technology
Stents, Peripheral
NeuroSigma Licenses UCLA's Thin-Film Nitinol Stent Technology
Cardiac Stem Cell/Regeneration therapy
First Heart Attack Patient Treated in European Cardioprotection Phase III Trial
